This trial will compare the success rates of two different types of surgery for treating a specific back problem. One type of surgery uses a special bone matrix mixed with allograft, while the other type of surgery uses autograft mixed with allograft. The trial will measure the success of the surgeries by looking at the rates of radiographic fusion and patient reported outcomes.
1 Primary · 6 Secondary · Reporting Duration: 12 months postoperative
40 Total Participants · 2 Treatment Groups
Primary Treatment: ViviGen® Cellular Bone Matrix · Has Placebo Group · N/A
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: